HR 4229
11 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Gave to its sponsors8 of 30
Alberta Harrison$24KKenneth H. Michael$23KKaren Harrison$22KHale Harrison$22KSteve Boozalis$21KScott Dorsey$19KMichael Macielag$18KMartin Morin$17KSponsors6 cosponsors more
Andy HarrisCongress · Maryland · RHR 4229
To amend the Impoundment Control Act of 1974 to require prior approval from Congress before the Comptroller General may pursue a civil action under such Act, and for other purposes
Congress · In committee
Every link on this map
The same connections as a table, with the reason each one is here.
| Alberta Harrison | Gave to its sponsors | Alberta Harrison gave $24K to a sponsor of HR 4229. A gift is not a position on the bill. | $24K |
| Kenneth H. Michael | Gave to its sponsors | Kenneth H. Michael gave $23K to a sponsor of HR 4229. A gift is not a position on the bill. | $23K |
| Karen Harrison | Gave to its sponsors | Karen Harrison gave $22K to a sponsor of HR 4229. A gift is not a position on the bill. | $22K |
| Hale Harrison | Gave to its sponsors | Hale Harrison gave $22K to a sponsor of HR 4229. A gift is not a position on the bill. | $22K |
| Steve Boozalis | Gave to its sponsors | Steve Boozalis gave $21K to a sponsor of HR 4229. A gift is not a position on the bill. | $21K |
| Scott Dorsey | Gave to its sponsors | Scott Dorsey gave $19K to a sponsor of HR 4229. A gift is not a position on the bill. | $19K |
| Michael Macielag | Gave to its sponsors | Michael Macielag gave $18K to a sponsor of HR 4229. A gift is not a position on the bill. | $18K |
| Martin Morin | Gave to its sponsors | Martin Morin gave $17K to a sponsor of HR 4229. A gift is not a position on the bill. | $17K |
| Andy Harris | Sponsors | Andy Harris sponsored HR 4229. | None |
| National Treasury Employees Union | Lobbied on it | National Treasury Employees Union named HR 4229 in 8 lobbying reports. | 8 reports |
| Takeda Pharmaceuticals America, Inc. | Lobbied on it | Takeda Pharmaceuticals America, Inc. named HR 4229 in 6 lobbying reports. | 6 reports |